Publication: Specificity of fetal tricuspid regurgitation in prediction of down syndrome in Thai fetuses at 17-23 weeks of gestation
Issued Date
2009-09-01
Resource Type
ISSN
01252208
01252208
01252208
Other identifier(s)
2-s2.0-70349293684
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of the Medical Association of Thailand. Vol.92, No.9 (2009), 1123-1130
Suggested Citation
Sanitra Anuwutnavin, Prapat Wanitpongpan, Pharuhas Chanprapaph Specificity of fetal tricuspid regurgitation in prediction of down syndrome in Thai fetuses at 17-23 weeks of gestation. Journal of the Medical Association of Thailand. Vol.92, No.9 (2009), 1123-1130. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/27949
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Specificity of fetal tricuspid regurgitation in prediction of down syndrome in Thai fetuses at 17-23 weeks of gestation
Other Contributor(s)
Abstract
Objective: To assess the specificity of tricuspid regurgitation (TR) in prediction of Down syndrome in Thai fetuses at 17-23 weeks' gestation and to determine the prevalence of TR among normal chromosome fetuses in a high-risk population. Material and Method: A prospective study was performed in 395 high-risk pregnant women who underwent amniocentesis or cordocentesis for fetal karyotyping at 17-23 weeks. The presence or absence of TR was determined by pulsed wave Doppler at the time of prenatal diagnosis. TR was diagnosed when the regurgitation flow was observed for at least half of systole or ≥ 70 milliseconds with maximum velocity of ≥ 100 cm/sec. The diagnostic values of TR for detection of Down syndrome were calculated. Results: The prevalence of TR was 3.8% (14/370) in normal chromosome fetuses and 40% (2/5) in Down syndrome fetuses. Fetuses with TR had a higher chance to be Down syndrome (11.1%) than those without TR (0.8%) (95% CI of the difference, 0.09-32.9, p = 0.036). Specificity, sensitivity, NPV and PPV of TR in prediction of Down syndrome were 95.9%, 40%, 99.2% and 11.1%, respectively. Among normal chromosome fetuses with TR, 14.3% (2/14) had congenital cardiac abnormalities. Conclusion: TR is not only a high specificity secondary ultrasound marker at 17-23 weeks to identify fetuses with Down syndrome in high-risk pregnant women but also associates with the risk of cardiac defects in normal chromosome fetuses.